Most microdosing schedules call for dosing one day followed by two or three days off, repeating that cycle for four to eight weeks before taking a longer break. The rest days aren’t arbitrary. They exist because your brain’s serotonin receptors start to lose sensitivity within 24 hours of a dose, and spacing days out helps prevent that tolerance from building.
The Two Most Common Schedules
The most widely referenced approach is the Fadiman protocol, named after psychologist James Fadiman. It follows a simple three-day cycle: dose on day one, then take two full days off before dosing again. So if you dose on Monday, your next dose would be Thursday. The logic is that each microdose may produce residual effects lasting one to two days afterward, meaning you’re still getting some benefit on your off days while giving your receptors time to reset.
The second popular approach, associated with mycologist Paul Stamets, follows a different rhythm: four days on, three days off. This protocol typically pairs psilocybin with lion’s mane mushroom and niacin, and it’s designed around the idea that consecutive low doses might have a compounding effect on neuroplasticity. The three-day break at the end of each week serves the same purpose as the Fadiman rest days, preventing tolerance.
Both protocols generally run for four to eight weeks before a longer reset period of two to four weeks. This on-off cycling is a consistent recommendation across microdosing communities, though formal clinical guidance on ideal cycle length doesn’t yet exist.
Why Rest Days Matter
Psychedelics work primarily by binding to a specific type of serotonin receptor in the brain. When that receptor gets activated repeatedly, your brain responds by pulling some of those receptors offline, a process called downregulation. Research in animal models has shown that receptor density in the frontal cortex drops significantly within just 24 hours of dosing. Fewer available receptors means each subsequent dose has less impact.
This is the same mechanism behind the well-known tolerance effect with full psychedelic doses, where taking the same amount two days in a row produces a noticeably weaker experience. At microdose levels the effect is subtler, but the biology is the same. Rest days allow receptor populations to return to baseline, so each dosing day starts fresh.
Does Exact Frequency Change the Results?
One of the more interesting findings from early research is that exact dosing frequency may matter less than people assume. A systematic study published in PLOS One tracked participants across different microdosing schedules and found significant improvements in depression and stress scores over the study period. But when researchers compared people who dosed more frequently against those who dosed less often, there was no significant difference in outcomes. The improvements showed up regardless of whether someone took a single dose or dosed relatively frequently during the study window.
This doesn’t mean daily dosing is equivalent to spaced dosing. It suggests that once you’re engaging with a microdosing practice at some reasonable frequency, the specific number of doses per week may be less critical than consistency over time. If you miss a scheduled dose day, it’s probably not derailing your results.
What Counts as a Microdose
Frequency only makes sense in context of how much you’re taking each time. A microdose is defined as sub-perceptual, meaning you shouldn’t feel “high” or experience any visual changes. For dried psilocybin mushrooms, this typically falls between 0.1 and 0.5 grams. For LSD, the equivalent range starts around 5 to 20 micrograms, with 0.1 grams of dried mushrooms roughly equivalent to about 5 micrograms of LSD.
If you notice perceptual effects (colors seeming brighter, mild visual distortion, difficulty concentrating), the dose is too high regardless of your schedule. Many people start at the lowest end and adjust upward slowly across multiple dosing days.
Timing Within the Day
Most protocols recommend morning dosing. Clinical research on psilocybin has typically administered doses around 9 a.m. Sleep studies suggest that daytime psilocybin doesn’t significantly disrupt total sleep time or sleep efficiency, though some people report it takes slightly longer to fall asleep. Taking a microdose in the afternoon or evening increases the chance of that mild sleep-onset delay, which is why morning dosing is standard practice.
A Potential Long-Term Concern
One area researchers are watching closely involves heart health. Both LSD and psilocybin interact with a serotonin receptor subtype found in heart valve tissue. Other drugs that chronically activate this receptor (some older diet pills and migraine medications) have been linked to cardiac fibrosis, a thickening and stiffening of heart valve tissue. Whether microdoses are potent enough or frequent enough to trigger this effect is unknown, but it’s the primary reason most protocols recommend cycling off for several weeks rather than dosing indefinitely. Keeping your total exposure intermittent, with regular breaks, is the most conservative approach until more safety data exists.
How to Track What’s Working
Because microdoses are sub-perceptual, the effects are subtle enough that you can easily miss them or misattribute them without some form of tracking. The Fadiman protocol asks participants to rate their day on dosing days and off days alike, which helps separate actual effects from expectation. Simple daily notes covering mood, energy, focus, sleep quality, and anxiety levels give you enough data to spot patterns after two or three weeks. Pay particular attention to how you feel on your second off day. If you notice the benefits fading completely by then, a slightly tighter schedule (like four days between doses instead of three) might work better for you. If you feel overstimulated or slightly anxious on dose days, the dose itself may need to come down before you adjust frequency.
Most people settle into a rhythm within the first two weeks. The first cycle is largely calibration, finding the dose and spacing that produces a baseline improvement without any perceptual effects or side effects like jitteriness or headaches.